期刊文献+

先天性心脏病合并重度肺动脉高压的诊断性治疗 被引量:2

The diagnostic treatment in congestive heart disease associated with severe pulmonary arterial hypertension
下载PDF
导出
摘要 目的探讨先天性心脏病(简称先心病)合并重度肺动脉高压患者手术指征的判断及围手术期治疗策略。方法总结2008年1月至2011年12月海军总医院收治的先心病合并重度肺动脉高压患者83例,其中室间隔缺损65例,房间隔缺损8例,动脉导管未闭5例,右室双出口3例,主动脉缩窄及主动脉弓离断各1例,给予强心、利尿、选择性扩张肺动脉的药物治疗;选择同期16例患者为对照组,仅给予强心、利尿治疗。监测末梢血氧饱和度变化,以氧饱和度稳定在95%以上为标准,判断手术指征。结果治疗组手术64例(77.1%),围手术期死亡2例,无远期死亡患者。对照组手术5例(31.3%),远期死亡1例。结论通过药物对重度肺动脉高压患者进行诊断性治疗,可以对肺动脉高压性质做出准确的判断,判断手术指征,降低手术死亡率,获得良好的疗效。 Objective To evaluate the operative indications and the perioperative management of congestive heart disease complicated with severe pulmonary hypertension. Methods From January 2008 to December 2011, 83 patients suffered congestive heart disease associated with severe pulmonary hypertension including ASD, VSD, PDA and DORV, were prescribed selective pulmonary vasodilator drugs. Sixteen patients in the control group were treated without these drugs. Operative indications were based on the changes of SpO 2 , echocardiogram and X-ray. Results After the pre-operative preparation, 65(77.1%) operations were performed. one patient died 6 days after the operation; only 5 (31.2%)operations were performed in the control group and no patient died. The follow-up showed that the pulmonary pressure was significantly decreased. Conclusion Satisfactory results can be achieved in the treatment of congestive heart disease with severe pulmonary hypertension by preoperative analysis of surgical indications.
出处 《北京医学》 CAS 2012年第7期539-541,共3页 Beijing Medical Journal
关键词 先天性心脏病 肺动脉高压 诊断性治疗 Congestive heart disease Pulmonary artery hypertension Diagnostic treatment
  • 相关文献

参考文献11

二级参考文献57

  • 1Singh TP,Rohit M,Grover A,菅鑫妍.口服西地那非疗法治疗严重肺动脉高压的效果研究[J].中国处方药,2006(8):29-29. 被引量:49
  • 2[1]Gaine S. Pulmonary hypertension. JAMA, 2000, 284:3160-3168. 被引量:1
  • 3[2]Heath D, Edwards J. A description of six grades of structural changes in the pulmonary arteries with special reference to congenital cardiac septal defects. Circulation, 1958, 18:533-547. 被引量:1
  • 4[3]Kidd L, Driscoll D, Gersony W, et al. Second natural history study of congenital heart defects. Results of treatment of patients with ventricular septal defects. Circulation, 1993, 87:138-151. 被引量:1
  • 5[4]Vogel M, Berger F, Kramer A, et al. Incidence of se-condary pulmonary hypertension in adults with atrial septal or sinus venosus defects. Heart, 1999, 82:30-33. 被引量:1
  • 6[5]Jeffery T K, Morrell N W. Molecular and cellular basis of pulmonary vascular remondeling in pulmonary hypertension. Prog Cardiol Dis, 2002, 45:173-202. 被引量:1
  • 7[6]Geiger R, Berger R M, Hess J, et al. Enhanced expression of vascular endothelial growth factor in pulmonary plexogenic arteriopathy due to congenital heart disease. J Pathol, 2000, 191:202-207. 被引量:1
  • 8[7]Tuder R M, Cool C D, Yeager M, et al. The pathobiology of pulmonary hypertension. Endothelium. Clin Chest Med, 2001, 22:405-418. 被引量:1
  • 9[8]Davie N, Haleen S J, Upton P D, et al. ET(A) and ET(B) receptors modulate the proliferation of human pulmonary artery smooth muscle cells. Am J Respir Crit Care Med, 2002, 165:398-405. 被引量:1
  • 10[9]Gries A, Bode C, Peter K, et al. Inhaled nitric oxide inhibits human platelet aggregation, P-selectin expression, and fibrinogen binding in vitro and in vivo. Circulation, 1998, 97:1481-1487. 被引量:1

共引文献55

同被引文献8

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部